Volker Knappertz

Volker Knappertz

EVP, Research and DevelopmentatAurinia Pharmaceuticals· In proxies 2021–2023

Pay in FY2023+15% from the year before · Aurinia Pharmaceuticals stock +108.1% the same year

Volker Knappertz was paid $3.4M in FY2023 (Dec), up 15%. Aurinia Pharmaceuticals stock rose 108.1% that year.

Pay$100 in the stock at the end of FY20 → $65
Pay is from the Summary Compensation Table of each Aurinia Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Aurinia PharmaceuticalsPublic company · 5 yr
    • EVP, Research and Development2021 – Present · 5 yrStock in role +22%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?